MSB 3.21% $1.13 mesoblast limited

MSB Trading - 2020, page-7993

  1. 7,859 Posts.
    lightbulb Created with Sketch. 1350
    No one will ignore positive phase 3 results.

    The hurdle is that phase 3 trials is traditionally where stem cell therapies fail to show significant benefit, despite having promising phase 1 and 2 results. Just look at the literature to see for yourself.

    So wait and see, if these results are good people won't ignore it. There's no big conspiracy.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.